Vertex Pharma drops as UnitedHealth offers Tier 3 coverage for new pain medicine

Vertex Pharmaceuticals (NASDAQ:VRTX) ended a four-day winning streak on Thursday after UnitedHealth (NYSE:UNH) placed its new pain medication Journavx in a less favorable Tier 3 coverage in two commercial formularies.

According to a formulary update from UnitedHealth’s (NYSE:UNH) Pharmacy